Ratings Encres DUBUIT

Equities

ALDUB

FR0004030708

Market Closed - Euronext Paris 11:21:12 2024-04-26 am EDT 5-day change 1st Jan Change
3.14 EUR +0.64% Intraday chart for Encres DUBUIT -1.26% -3.09%

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

  • The stock, which is currently worth 2023 to 0.3 times its sales, is clearly overvalued in comparison with peers.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • Low profitability weakens the company.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.

Ratings chart - Surperformance

Sector: Specialty Chemicals

1st Jan change Capi. Investor Rating ESG Refinitiv
-3.09% 10.2M -
+9.29% 4B
D+
+5.18% 1.75B
B+
+3.44% 979M
D+
+9.13% 966M -
+66.88% 752M - -
-2.47% 692M - -
+31.71% 600M
B-
-1.29% 553M -
+15.68% 499M -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality